Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer

NCT00392392 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab-paclitaxel
DRUG: Bevacizumab
DRUG: Trastuzumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]